Early detection of Type 1 diabetes in children and adolescents who have a parent or sibling with Type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This protocol offers standardized screening, monitoring, and data collection for young people at increased risk because they have a first-degree relative with Type 1 diabetes. Participation lasts about 13 months and includes two visits: an initial screening visit and a confirmatory follow-up visit. Clinical tests and brief visits are used to identify pre-symptomatic disease and to confirm any findings. The program follows international recommendations for early detection and regional implementation at participating hospitals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children and adolescents, age 1.5 years to 18 years
* First degree relatives of T1D probands
* Parent or legal guardian signing an informed consent

Exclusion Criteria:

* Already developed clinical overt T1D
* Known diabetes of any kind (type 1, type 2, Maturity Onset Diabetes of the Young - MODY)
* Have a previous history of being treated with insulin

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where it's running

• Dasman Diabetes Institute - Site Number: 08
  Kuwait City, Al Asimah / Capital Governorate, Kuwait Recruiting
• Imam Abdulrahman Bin Faisal University - Site Number: 05
  Dammam, Eastern Province, Saudi Arabia Recruiting
• King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01
  Jeddah, Mecca Region, Saudi Arabia Recruiting
• King Fahd Medical City - Site Number: 03
  Riyadh, Saudi Arabia Recruiting
• King Faisal Specialist Hospital & Research Centre - Site Number: 02
  Riyadh, Saudi Arabia Recruiting
• Sheikh Khalifa Medical City - Site Number: 07
  Abu Dhabi, United Arab Emirates Recruiting

Study contacts

• Study coordinator: Trial Transparency email recommended (Toll free for US & Canada)
• Email: Contact-US@sanofi.com
• Phone: 800-633-1610

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

  This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

  Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

• Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes

  This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.

  Recruiting at 11 sites Medtronic MiniMed, Inc. · Chula Vista, California and 17 other locations · NCT07864168

• CGM-guided carb awareness education for adults with Type 1 diabetes

  This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.

  Recruiting University of California, Los Angeles · Los Angeles, California · NCT07807280

• Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes

  This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.

  Recruiting at 17 sites Indiana University · Newport Beach, California and 16 other locations · NCT07676565

• Think-Find-Solve activities for insulin self-management in children with type 1 diabetes

  A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.

  Recruiting Marmara University · Istanbul · NCT07670572

• Near-sensor insulin delivery with CGM in people with type 1 diabetes

  A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.

  Recruiting Early Phase 1 ClinSurge Research · Toronto, Ontario · NCT07655076

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.